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Autologous greater saphenous vein is considered to 
be the best bypass material for below knee femoro- 
popliteal and femorocrural arterial reconstructions. 
Although the patency rates of in situ bypasses are no 
better than reversed bypasses, 1 the in situ technique is 
the preferred technique in many clinics. 
Two mandatory procedures during the in situ 
bypass operation are the closure of side branches and 
the cutting of the valves. These procedures are often 
performed under direct vision, necessitating a com- 
plete exposure of the greater saphenous vein. A 
disadvantage of this technique is the high incidence of 
postoperative wound complications. In two retro- 
spective studies dealing with postoperative wound 
complications after in situ bypasses the incidences 
were 33% and 44%. 2'3 A logical step to reduce wound 
complications was the development of operating 
techniques with a reduced skin incision length. To 
allow selective ligation of side branches, via separate 
small incisions, the valvulotomy procedure must first 
be performed either "blindly" or under endoscopic 
control. The endoscopically controlled valvulotomy 
offers the advantage of direct visualisation of the 
effectiveness of the valvulotomy procedure. However 
Clair et al. showed in a randomised trial, 4 that 
endoscopically assisted in situ bypass grafting did not 
result in a better bypass performance. 
Angiograph~ a Doppler device or a Duplex scanner 
can be used peroperatively to identify and selectively 
ligate the side branches. 5"° Another option is to locate 
the side branches endoscopically. With this "semi- 
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closed" technique the need for one long skin incision 
is obviated, but several small skin incisions, beside the 
incisions necessary for the anastomoses, remain. 
The final step to a more "closed" technique, with 
less skin incision length, necessitates the closure of the 
side branches of the vein from the inside. Rosenthal et 
al. were the first to describe a series of these "closed" 
in situ bypasses. 7 They used an electronically steerable 
nitinol catheter system, to selectively, catheterise and 
coil-embolise the side branches of the vein. Peroper- 
ative coil-embolisation was performed under angio- 
scopic and fluoroscopic ontrol. In 46 patients a total 
number of 84 side branches ( < 2 per bypass) were per- 
operatively coil embolised. In 39 patients extra small 
skin incisions were necessary to ligate or clip side 
branches that could not be coil embolised. The 
occurrence of postoperative residual arteriovenous 
fistulae was not mentioned in this preliminary report. 
Wound complications occurred in only 6% of the 
patients, but no details about the severity of the 
wound complications were available. The one year 
patency rate (13 grafts at risk), was 84%. The authors 
did not mention if this was primary or secondary 
patency. 
Cikrit et al. used the same electronically steerable 
nitinol catheter system in a series of 30 patients (31 
limbs). 8 After the first 16 operations they abandoned 
the angioscopic ontrol during valvulotomy and coil 
embolisation. Valvulotomy was then performed 
blindly and the peroperative coil-embolisation was 
performed under fluoroscopic control only. In 31 
operations a total number of 97 side branches were 
coil embolised. During seven operations an extra skin 
incision was necessary to ligate side branches that 
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could not be embolised. In 39% of the cases residual 
arteriovenous fi tulae were treated postoperatively. In 
13% of the patients postoperative wound complica- 
tions were reported. Early graft failure (within 30 days 
of the operation) was 6%. One year patency rates were 
not reported. Chervu et aI. described their initial 
experience in three patients. 9 In two patients wound 
complications occurred. Residual AV-fistulae were 
seen in two patients. The operation time was sig- 
nificantly prolonged (1-5 h increase) by the endovas- 
cular coil embolisation procedure. 
Wittens et al. describe apilot series of 14 patients (16 
limbs: 12 below knee femoropopliteal nd 4 femoro- 
crural).l ° They used a variable valvecutter for "bhnd" 
valvulotomy and a coaxial catheter system for the 
peroperative coil embolisation of the side branches. 
Fluoroscopic ontrol was used during the coil emboli- 
sation procedure. In 16 operations 122 side branches 
were peroperatively coil-embolised. In four patients 
(25%) postoperative residual arteriovenous fistulae 
were treated. In two patients (13%) a major wound 
complication occurred. One year primary patency was 
81% for the femoropopliteal and 50% for the femoro- 
crural bypasses. Following this pilot stud)~ a rando- 
mised multi-centre trial was performed. 11Forty-seven 
"closed" in situ bypass procedures were compared to 
50 "open" procedures. In the 47 "closed" procedures 
272 side branches were coil embolised. In three of 
these patients additional skin incisions were necessary 
for ligation of side branches that could not be coil 
embolised. In two patients all side branches were 
ligated via skin incisions because of failure of the 
peroperative coil embolisation. All five were due to 
the small diameter of the vein of less than 3mm. In 
42% of the "closed" procedures residual AV fistulae 
were treated compared to 8% in the "open" group. 
Total wound complication rates were 36% in the 
"closed" group compared to 72% in the "open" group. 
One year primary patency rates were similar for both 
patient groups. 
Peroperative endovascular obliteration of side 
branches during in situ bypass procedures now 
appears feasible. However as pointed out very clearly 
by Chervu et al. 9 it is a costly and time consuming 
procedure specially when learning the technique. 
Successful embolisation-catheter manipulation 
requires a well trained operating team and optimal 
fluoroscopy for visualisation of the embolisation 
procedure. Since the quality of the greater saphenous 
vein is one of the factors influencing the outcome of an 
in situ bypass 12'~3 and a diameter > 3mm and a normal 
anatomy are obligatory for a "closed" procedure, 
preoperative assessment of the vein is recommended. 
Currently ultrasound seems the best tool for this 
preoperative vein mapping. 14"15 
The "closed" in situ bypass technique reduces the 
wound complication rates significantly compared to 
the "open" technique. 11 Since the "closed" in situ 
bypass operation is more expensive, other patient 
treatment costs have to be less, to make the "closed" in 
situ bypass procedure worthwhile in a pure economic 
perspective. The reduction of wound complication 
rates could lead to a shortened hospital stay and 
reduced outpatient or community care. However in 
the study of Van Dijk et al., 11 no significant reduction 
in hospital stay was seen, due to concommitant 
disease. By including outpatient care, a significant 
reduction in wound healing time was found, namely 
18 days for the closed technique vs. 42 days for the 
open technique. A cost-effectiveness study comparing 
the financial as well as the medical consequences of 
the different operating technique is needed to answer 
the important question whether this new technique is
acceptable in countries with a financially restricted 
health-care system. 
A serious problem of the "closed" technique seems 
to be the high percentage of postoperative r sidual 
arteriovenous fistulae. Cikrit et al. reported that 39% 
and Van Dijk et al. that 42% of the patients received 
treatment for postoperative r sidual AV fistulae after a 
"closed" in situ bypass procedure. Treatment of these 
residual AV fistulae can be performed operatively or 
by percutaneous coil-embolisation. 16'17 Currently no 
generally accepted treatment criteria for residual AV 
fistulae are available. Since Chang et al. is have shown 
that in the majority of residual AV fistulae do not affect 
distal bypass flow and patency, it is possible that in the 
above mentioned studies, too many AV fistulae were 
treated postoperatively. 
In conclusion we can state that the "closed" in situ 
bypass technique, using peroperative ndovascular 
obliteration of the side branches is a promising new 
technique and potentially the new standard for in situ 
bypasses. The first encouraging results have to be 
corroborated by other studies, the problems of resid- 
ual postoperative AV fistulae have to be solved and 
cost-effectiveness studies are needed to establish the 
role of this technique in the future. 
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